Employer group launches depression treatment plan

MINNEAPOLIS?Employer coalition Bridges to Excellence is launching a pay-for-performance program that will reward physicians for optimal treatment of depression.
From: www.businessinsurance.com

Groundbreaking Approach for Improving Depression Care Introduced at 10 Minnesota Clinics

Ten primary care clinics in the Twin Cities, Duluth and Rochester are the first in Minnesota to offer a new, more effective approach for caring for patients with depression. To date, 234 patients have been enrolled in the program -- called Depression Improvement Across Minnesota, Offering a New Direction, or "DIAMOND" -- since it began in March.
From: biz.yahoo.com

Mental health levy set for ballot

If only getting approval from Wood County voters were so easy.The Wood County Alcohol, Drug Addiction and Mental Health Services...
From: www.sent-trib.com

Depression topic of SIfCC luncheon

Sixteen representatives from 14 different faith groups joined the board of directors and staff from the Stillwater Interfaith Counseling Center (SIfCC) for their spring luncheon.
From: www.stillwater-newspress.com

Mylan shares dip as the company cuts profit guidance

Shares of Mylan Inc. fell Friday after the generic drug developer cut its profit guidance spanning the next several years, though Wall Street expects the company to meet the new targets.
From: biz.yahoo.com

Depression diversity: Brain studies reveal big differences among individuals

ANN ARBOR, Mich. - Depressed people may have far fewer of the receptors for some of the brain?s ?feel good? stress-response chemicals than non-depressed people, new University of Michigan Depression Center research shows.
From: www.eurekalert.org

AFX UK Focus) 2008-05-07 07:46 Lundbeck Q1 EBIT beats consensus; reiterates full-year guidance

COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Lundbeck AS posted first-quarter EBIT of 924 million Danish crowns, up 40 percent from a year earlier on the back of stronger sales and margins, and significantly ahead of consensus estimates according to RB Boersen for 699 million crowns.
From: www.iii.co.uk

Depression Treatments Reviewed by NeuroInvestment

NeuroInvestment today announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly aversive side effects for the majority.
From: biz.yahoo.com

Kids And Health: Treatment for depression has improved

It is estimated that at some point, 10 percent to 15 percent of children and adolescents have some symptoms of depression. The bad news is that major depression in children is very serious. The good news is that depression is treatable.
From: seattlepi.nwsource.com

Wyeth research chief Ruffolo to retire

NEW YORK, April 30 - Wyeth on Wednesday said its pharmaceuticals research chief Robert Ruffolo will retire later this year and be replaced by Mikael Dohlsten, a former senior executive of privately held German drugmaker Boehringer Ingelheim.
From: sg.news.yahoo.com

Sanofi-Aventis 1Q profits hurt by generic competition

French drug maker Sanofi-Aventis on Wednesday reported a 12 percent drop in first-quarter adjusted net profit as the weak dollar and generic competition bit into sales of its sleep and cancer drugs.
From: biz.yahoo.com